NCLT Sanctions Dr. Agarwals Eye Hospital Amalgamation Scheme

NCLT Order Date: September 30, 2026; Appointed Date: April 01, 2026.

Reader Takeaway: Consolidation clears regulatory hurdles, pending final compliance and share exchange record date announcements.

What just happened

The Chennai Bench of the National Company Law Tribunal (NCLT) has officially sanctioned the Scheme of Amalgamation involving Dr. Agarwals Eye Hospital Ltd (AEHL) and Dr. Agarwals Health Care Ltd (AHCL). The order, pronounced on September 30, 2026, and made available on October 5, 2026, provides the necessary legal mandate for the entities to merge under Sections 230 to 232 of the Companies Act, 2013.

Why this matters

This approval is a pivotal regulatory step in the group's internal restructuring. By consolidating Dr. Agarwals Health Care Ltd into the listed entity, the company aims to unify its corporate structure. For investors, this marks the transition from the legal approval phase to the operational integration phase, which will eventually include the issuance of shares to eligible shareholders.

What changes now

While the scheme is legally sanctioned, it is not yet fully operative. The 'Appointed Date' is set for April 1, 2026. The 'Effective Date'—the point at which the merger is fully recognized—will occur on the first day of the month following the fulfillment of all conditions precedent outlined in the scheme’s Clause 24.

What to track next

Investors should keep a close watch on future BSE filings for three specific updates:

• The formal notification of the 'Effective Date'.
• The announcement of the 'Record Date' for identifying eligible shareholders.
• Details regarding the final share exchange ratio and the subsequent allotment process.